Evidence map›Paper›PMID 40969766›Full record

ReviewFrontiers in immunology2025

Ferroptosis in pain: evidence, challenges, and opportunities.

Qianqian Yan, Fang Wang, Mengyuan Liu, Jinyan Mao, Zihao Zhao, Bo Wang

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qianqian Yan *Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China.
Fang Wang *Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China.
Mengyuan LiuDepartment of Anesthesiology, Air Force Hospital of Western Theater Command, PLA, Chengdu, China.
Jinyan MaoDepartment of Anesthesiology, Air Force Hospital of Western Theater Command, PLA, Chengdu, China.
Zihao ZhaoNephrology Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bo WangDepartment of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain, an unpleasant but essential feeling for life, affects more than 20% of the global population and burdens health and the economy. Due to the lack of understanding of the exact fundamental mechanism, the existing therapeutic strategies for pain offer finite efficacy and troublesome side effects. The intricacy of the pathogenesis of pain enormously hinders the exploitation of therapeutic approaches. Ferroptosis is a novel mode of cell death characterized by mitochondrial damage, oxidative stress, massive intracellular iron accumulation, and lipid peroxidation. Multiple studies have demonstrated that ferroptosis is involved in the development of pain. We aim to focus on the underlying mechanisms by which ferroptosis participates in pain and recent findings on targeted therapies for ferroptosis in painful diseases. In this review, first, the pivotal mechanisms of ferroptosis are briefly summarized. Second, how ferroptosis participates in pain response is described. Finally, we summarized some substances that relieve pain by alleviating lipid peroxidation and iron accumulation and modulating ferroptosis. We propose that targeting ferroptosis holds tremendous promise in preventing and treating painful diseases.

Indexed as

FerroptosisPainAnimalsHumansIronLipid PeroxidationOxidative StressIronferroptosisiron dyshomeostasislipid peroxidationoxidative stresspain

Identifiers

PMID40969766
PMCPMC12440755

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.